BiotechTube
Home/NeuroPace/Rebecca Kuhn
RK

Rebecca Kuhn

Chief Financial Officer

NeuroPace

Therapeutic Areas

EpilepsyNeurological Disorders

NeuroPace Pipeline

DrugIndicationPhase
RNS System - NAUTILUS StudyIdiopathic Generalized Epilepsy (IGE)Pivotal Trial
RNS System - Long-Term Post-Approval StudyDrug-Resistant Focal EpilepsyPost-Market
nSight PDMSEpilepsy Data ManagementCommercial

Leadership Team at NeuroPace

JB
Joel Becker
Chief Executive Officer
MM
Martha Morrell, M.D.
Chief Medical Officer
DG
David Greene, Ph.D.
Chief Technology Officer
FF
Frank Fischer
Chairman of the Board
View full NeuroPace profile